Cyclic nucleotide specificity of the activator and catalytic sites of a cGMP-stimulated cGMP phosphodiesterase from Dictyostelium discoideum. 1985

F Kesbeke, and J Baraniak, and R Bulgakov, and B Jastorff, and M Morr, and G Petridis, and W J Stec, and F Seela, and P J Van Haastert

The cellular slime mold Dictyostelium discoideum has an intracellular phosphodiesterase which specifically hydrolyzes cGMP. The enzyme is activated by low cGMP concentrations, and is involved in the reduction of chemoattractant-mediated elevations of cGMP levels. The interaction of 20 cGMP derivatives with the activator site and with the catalytic site of the enzyme has been investigated. Binding of cGMP to the activator site is strongly reduced (more than 80-fold) if cGMP is no longer able to form a hydrogen bond at N2H2 or O2'H. Modifications at N7, C8, O3' and O5' induce only a small reduction of binding affinity. A cyclic phosphate structure, as well as a negatively charged oxygen atom at phosphorus, are essential to obtain activation of the enzyme. Substitution of the axial exocyclic oxygen atom by sulphur is tolerated; modification of the equatorial oxygen atom reduces the binding activity of cGMP to the activator site by 90-fold. Binding of cGMP to the catalytic site is strongly reduced if cGMP is modified at N1H, C6O, C8 and O3', while modifications at N2H2, N3, N7, O2'H, and O5' have minor effects. Both exocyclic oxygen atoms are important to obtain binding of cGMP to the catalytic site. The results indicate that activation of the enzyme by cGMP and hydrolysis of cGMP occur at different sites of the enzyme. cGMP is recognized at these sites by different types of molecular interaction between cGMP and the protein. cGMP derivatives at concentrations which saturate the activator site do not induce the same degree of activation of the enzyme (activation 2.3-6.6-fold). The binding affinities of the analogues for the activator site and their maximal activation are not correlated. Our results suggest that the enzyme is activated because cGMP bound to the activator site stabilizes a state of the enzyme which has a higher affinity for cGMP at the catalytic site.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D004023 Dictyostelium A genus of protozoa, formerly also considered a fungus. Its natural habitat is decaying forest leaves, where it feeds on bacteria. D. discoideum is the best-known species and is widely used in biomedical research. Dictyostelium discoideum,Dictyostelium discoideums,Dictyosteliums,discoideum, Dictyostelium
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

F Kesbeke, and J Baraniak, and R Bulgakov, and B Jastorff, and M Morr, and G Petridis, and W J Stec, and F Seela, and P J Van Haastert
April 1983, European journal of biochemistry,
F Kesbeke, and J Baraniak, and R Bulgakov, and B Jastorff, and M Morr, and G Petridis, and W J Stec, and F Seela, and P J Van Haastert
January 1974, Methods in enzymology,
F Kesbeke, and J Baraniak, and R Bulgakov, and B Jastorff, and M Morr, and G Petridis, and W J Stec, and F Seela, and P J Van Haastert
April 2005, European journal of pharmacology,
F Kesbeke, and J Baraniak, and R Bulgakov, and B Jastorff, and M Morr, and G Petridis, and W J Stec, and F Seela, and P J Van Haastert
July 1981, The Journal of biological chemistry,
F Kesbeke, and J Baraniak, and R Bulgakov, and B Jastorff, and M Morr, and G Petridis, and W J Stec, and F Seela, and P J Van Haastert
February 1984, The Journal of cell biology,
F Kesbeke, and J Baraniak, and R Bulgakov, and B Jastorff, and M Morr, and G Petridis, and W J Stec, and F Seela, and P J Van Haastert
August 1989, The Journal of biological chemistry,
F Kesbeke, and J Baraniak, and R Bulgakov, and B Jastorff, and M Morr, and G Petridis, and W J Stec, and F Seela, and P J Van Haastert
February 1989, Developmental biology,
F Kesbeke, and J Baraniak, and R Bulgakov, and B Jastorff, and M Morr, and G Petridis, and W J Stec, and F Seela, and P J Van Haastert
July 1981, The Journal of biological chemistry,
F Kesbeke, and J Baraniak, and R Bulgakov, and B Jastorff, and M Morr, and G Petridis, and W J Stec, and F Seela, and P J Van Haastert
April 1987, The Journal of biological chemistry,
F Kesbeke, and J Baraniak, and R Bulgakov, and B Jastorff, and M Morr, and G Petridis, and W J Stec, and F Seela, and P J Van Haastert
March 1972, Science (New York, N.Y.),
Copied contents to your clipboard!